DGAP-News: Nidda Healthcare Holding AG

Nachricht vom 22.09.2017 (www.4investors.de) -


DGAP-News: Nidda Healthcare Holding AG / Schlagwort(e): Anleihe

Nidda Healthcare Holding AG
22.09.2017 / 14:27


Für den Inhalt der Mitteilung ist der Emittent verantwortlich.
Frankfurt, Germany, September 22, 2017. Nidda Healthcare Holding AG, an Aktiengesellschaft organized under the laws of Germany (the "Senior Secured Notes Issuer"), and Nidda BondCo GmbH, a Gesellschaft mit beschränkter Haftung organized under the laws of Germany (the "Senior Notes Issuer" and, together with the Senior Secured Notes Issuer, the "Issuers"), announced today that they have priced their offering of Notes (as defined below). The Senior Secured Notes Issuer has priced its EUR735,000,000 in aggregate principal amount of Senior Secured Notes due 2024 (the "Senior Secured Notes") at par, with a cash coupon of 3.5% per annum. In addition, the Senior Notes Issuer has priced its EUR340,000,000 in aggregate principal amount of Senior Notes due 2025 (the "Senior Notes" and, together with the Senior Secured Notes, the "Notes") at par, with a cash coupon of 5% per annum. The closing of the sale of the Notes is scheduled to be completed on September 29, 2017, and is subject to customary conditions.
The net proceeds from the offering of the Notes (i) will be used to refinance each Issuer's indebtedness outstanding under their EUR485,000,000 senior secured bridge term loan facility and EUR340,000,000 senior bridge term loan facility (together, the "Bridge Facilities"), respectively, and pay fees in connection with such offering and (ii) will be deposited into a secured account for future utilization. The indebtedness under the Bridge Facilities was incurred to finance part of the purchase price for the Senior Secured Notes Issuer's acquisition of approximately 64% of the outstanding common shares in STADA Arzneimittel AG ("STADA"), on August 22, 2017.
The Notes are being offered only to qualified institutional buyers in accordance with Rule 144A under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and outside the United States to non-U.S. persons in accordance with Regulation S under the Securities Act and, if an investor is a resident of a member state of the European Economic Area (the "EEA"), only to an investor that is a qualified investor (within the meaning of Article 2(1)(e) of Directive 2003/71/EC, together with any amendments thereto, including Directive 2010/73/EU, to the extent implemented in the relevant member state (the "Prospectus Directive")).
****************
 This document is not an offer of securities for sale in the United States. The Notes may not be sold in the United States unless they are registered under the Securities Act or are exempt from registration. The offering of Notes described in this press release has not been and will not be registered under the Securities Act, and accordingly any offer or sale of Notes may be made only in a transaction exempt from the registration requirements of the Securities Act.
 It may be unlawful to distribute this document in certain jurisdictions. This document is not for distribution in Canada, Japan or Australia. The information in this document does not constitute an offer of securities for sale in Canada, Japan or Australia.
 This document has been prepared on the basis that any offer of the Notes in any member state of the EEA which has implemented the Prospectus Directive (each, a "Relevant Member State") will be made pursuant to an exemption under the Prospectus Directive, as implemented in that Relevant Member State, from the requirement to publish a prospectus for offers of Notes. Accordingly any person making or intending to make any offer in that Relevant Member State of the Notes which are the subject of the placement contemplated in this document may only do so in circumstances in which no obligation arises for the Issuers or any of the initial purchasers of such Notes to publish a prospectus pursuant to Article 3 of the Prospectus Directive or supplement a prospectus pursuant to Article 16 of the Prospectus Directive, in each case, in relation to such offer. Neither the Issuers nor the initial purchasers of such Notes have authorized, nor do they authorize, the making of any offer of Notes in circumstances in which an obligation arises for the Issuers or any initial purchasers of such Notes to publish or supplement a prospectus for such offer.
 This document is only being distributed to, and is only directed at, persons in the United Kingdom that are "qualified investors" within the meaning of Article 2(1)(e)(i), (ii) or (iii) of the Prospectus Directive and that also (i) are "investment professionals" falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the "Order"), (ii) are persons falling within Article 49(2)(a) to (d) (high net worth companies, unincorporated associations, etc.) of the Order, or (iii) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "relevant persons"). This document is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this document relates is available only to relevant persons and will be engaged in only with relevant persons.
 Neither the content of STADA's or the Issuers' website nor any website accessible by hyperlinks on STADA's or the Issuers' website is incorporated in, or forms part of, this announcement. The distribution of this announcement may be restricted by law. Persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.
 No money, securities or other consideration is being solicited, and, if sent in response to the information contained herein, will not be accepted.
 This press release may include projections and other "forward-looking" statements within the meaning of applicable securities laws. Forward-looking statements are based on current expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the results of the Issuers and their subsidiaries or their respective industries' actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. You should not place undue reliance on forward-looking statements and the Issuers and their subsidiaries do not undertake publicly to update or revise any forward-looking statement that may be made herein, whether as a result of new information, future events or otherwise.










22.09.2017 Veröffentlichung einer Corporate News/Finanznachricht, übermittelt durch DGAP - ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.Die DGAP Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen. Medienarchiv unter http://www.dgap.de



612201  22.09.2017 





PfeilbuttonAURELIUS: „2017 wird das beste Jahr in unserer Unternehmensgeschichte” - Exklusiv-Interview
PfeilbuttonHanseYachts: „Unser Verkaufsapparat läuft inzwischen wie eine geölte Maschine“ - Exklusiv-Interview
PfeilbuttonNOXXON Pharma: DEWB-Beteiligung steht vor wichtigen Meilensteinen - Exklusiv-Interview


+++ Exklusive Interviews und Analysen - gratis in Ihre Mailbox! +++

Tragen Sie sich jetzt für unseren kostenlosen 4investors Newsletter ein.


Bestätigungslink nicht per Mail bekommen? Bitte kontrollieren Sie Ihren Spamordner!

Der 4investors Newsletter erscheint unregelmäßig, i.d.R. 2 bis 6 Mal pro Monat. Wir geben ihre Mailadresse an keinen Dritten weiter! Sie können den kostenlosen 4investors Newsletter jederzeit problemlos wieder abbestellen.
comments powered by Disqus


Aktuelle Nachrichten aus der 4investors-Redaktion

20.10.2017 - Hypoport Aktie stürzt ab - Zahlen enttäuschen
20.10.2017 - Evotec Aktie rauscht in die Tiefe - Shortseller schuld?
20.10.2017 - Syzygy legt Quartalszahlen vor
20.10.2017 - curasan: Planungen für 2017 werden gesenkt
20.10.2017 - Auden trennt sich von Teilen der OptioPay-Beteiligung
20.10.2017 - Aroundtown schließt Kapitalerhöhung ab
20.10.2017 - Metro sieht Impulse unter anderem im Onlinegeschäft
20.10.2017 - Uniper will Kraftwerk im Sommer stilllegen
20.10.2017 - Nordex Aktie: Jetzt wird es richtig kritisch!
20.10.2017 - CR Capital Real Estate: Kapitalherabsetzung wird umgesetzt


Chartanalysen

20.10.2017 - MBB Aktie: Boden nach dem „Aumann-Schock” in Sicht?
20.10.2017 - E.On Aktie: Was passiert hier gerade?
20.10.2017 - Morphosys Aktie: Die Lage spitzt sich zu!
20.10.2017 - BYD und Geely: Beide Aktie bleiben absturzgefährdet, aber...
19.10.2017 - Evotec Aktie: Das war es dann wohl, oder?
19.10.2017 - BYD und Geely: Aktien unter Druck - das wird jetzt ganz eng für die Bullen!
19.10.2017 - Medigene Aktie: Aus der Traum?
19.10.2017 - Commerzbank Aktie: Alles steht auf des Messers Schneide!
18.10.2017 - Evotec Aktie: Das kann noch gefährlich werden
18.10.2017 - BYD Aktie: Heißer Poker zwischen Bullen und Bären


Analystenschätzungen

20.10.2017 - Allianz Aktie: Aufwärtsbewegung vor dem Ende?
20.10.2017 - MBB Aktie: Neues Kursziel
20.10.2017 - Aumann Aktie bekommt Kaufempfehlung
20.10.2017 - Kion: Reihenweise senken sich die Daumen
20.10.2017 - Commerzbank Aktie: Kursziel deutlich erhöht, aber…
20.10.2017 - Daimler Aktie: So sehen die Experten die Quartalszahlen
19.10.2017 - Aixtron Aktie: Das Aus für die Bullen?
19.10.2017 - Commerzbank Aktie: Das dürfte den Bullen gar nicht in den Kram passen
19.10.2017 - Bayer Aktie bekommt Kaufempfehlung
19.10.2017 - Puma Aktie: Neue Expertenstimmen


Kolumnen

20.10.2017 - China stellt die Weichen - Weberbank-Kolumne
20.10.2017 - Xi Jinping stärkt seine Macht und die Macht der Kommunistischen Partei - Commerzbank Kolumne
20.10.2017 - Haushaltsentwurf passiert den US-Senat - National-Bank
20.10.2017 - Daimler Aktie: Neuer Aufwärtstrend hat sich etabliert - UBS Kolumne
20.10.2017 - DAX: Die Volatilität zieht deutlich an - UBS Kolumne
19.10.2017 - US-Wohnungsmarkt ohne Anzeichen einer Überhitzung - Commerzbank Kolumne
19.10.2017 - Erklärt Katalonien heute Morgen endgültig die Unabhängigkeit? - National-Bank
19.10.2017 - China: Wachstum glänzt auf den ersten Blick – im Hintergrund gärt es - VP Bank Kolumne
19.10.2017 - Vonovia Aktie: Neues Allzeithoch bestätigt Aufwärtstrend - UBS Kolumne
19.10.2017 - DAX: Der Widerstand ist gebrochen - UBS Kolumne

Werbung

All Right Reserved by minimalthemes - ©2014 Stoffels & Barck GbR